Table 3.
Univariated regression model between Lp-PLA2and cardiometabolic factors
| |
Lp-PLA2 |
||
|---|---|---|---|
| R2 | P* | β | |
|
BMI, kg/m2 |
0.038 |
0.003 |
0.195 |
|
WC, cm |
0.073 |
0.000 |
0.270 |
|
Fat mass,% |
0.034 |
0.004 |
0.186 |
|
TC, mg/dL |
0.035 |
0.004 |
0.186 |
|
LDL-C, mg/dL |
0.016 |
0.051 |
0.128 |
|
HDL-C, mg/dL |
0.001 |
0.671 |
−0.028 |
|
TG, mg/dL |
0.008 |
0.163 |
0.091 |
|
TG/HDL-C |
0.007 |
0.199 |
0.084 |
|
LDL-C/HDL-C |
0.010 |
0.121 |
0.121 |
|
TC/HDL-C |
0.018 |
0.042 |
0.133 |
|
Non HDL-C |
0.022 |
0.022 |
0.149 |
|
HDL-C/ApoAI |
0.001 |
0.585 |
0.036 |
|
Apo AI, mg/dL |
0.019 |
0.038 |
−0.137 |
|
Apo B, mg/dL |
0.082 |
0.000 |
0.293 |
|
Apo B/Apo AI |
0.118 |
0.000 |
0.343 |
|
LDL-C/ApoB |
0.000 |
0.775 |
−0.019 |
|
LDL(−), mg/mL |
0.001 |
0.706 |
0.025 |
|
Anti LDL(−), mg/mL |
0.013 |
0.078 |
−0.115 |
|
HDL size , nm |
0.085 |
0.000 |
−0.291 |
|
Insulin, uU/mL |
0.039 |
0.002 |
0.198 |
|
Glucose, mg/dL |
0.019 |
0.034 |
0.138 |
| HOMA-IR | 0.047 | 0.001 | 0.216 |
BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglycerides; LDL, low density lipoprotein; HDL, high density lipoprotein.
Variables in log form, except for percentages. *Significant level (P < 0.05).